UTILISATION DE (RS)-S-CYCLOPROPYL-S-(4-{[4-{[(1R, 2R)-2-HYDROXY-1-METHYLPROPYL]OXY}-5-(TRIFLUOROMETHYL)PYRIMIDIN-2-YL]AMINO}PHENYL)SULFOXIMIDE POUR LE TRAITEMENT DE TUMEURS SPECIFIQUES
The invention relates to the use of (R)-S-cyclopropyl-S-(4-{[4-{[(1R,2R)-2- hydroxy-1-methylpropyl]oxy}-5-(trifluoromethyl)pyrimidin-2-yl]amino}- phenyl)sulfoximide and/or (S)-S-cyclopropyl-S-(4-{[4-{[(1R,2R)-2- hydroxy-1-methylpropyl]oxy}-5-(trifluoromethyl)pyrimidin-2-yl]amino}- phenyl)sulfoximide for treatment of specific tumors.